Abstract
CACNA1C, encoding the Cav1.2 subunit of L-type Ca2+ channels, has emerged as one of the most prominent and highly replicable susceptibility genes for several neuropsychiatric disorders. Cav1.2 channels play a crucial role in calcium-mediated processes involved in brain development and neuronal function. Within the CACNA1C gene, disease-associated single-nucleotide polymorphisms have been associated with impaired social and cognitive processing and altered prefrontal cortical (PFC) structure and activity. These findings suggest that aberrant Cav1.2 signaling may contribute to neuropsychiatric-related disease symptoms via impaired PFC function. Here, we show that mice harboring loss of cacna1c in excitatory glutamatergic neurons of the forebrain (fbKO) that we have previously reported to exhibit anxiety-like behavior, displayed a social behavioral deficit and impaired learning and memory. Furthermore, focal knockdown of cacna1c in the adult PFC recapitulated the social deficit and elevated anxiety-like behavior, but not the deficits in learning and memory. Electrophysiological and molecular studies in the PFC of cacna1c fbKO mice revealed higher E/I ratio in layer 5 pyramidal neurons and lower general protein synthesis. This was concurrent with reduced activity of mTORC1 and its downstream mRNA translation initiation factors eIF4B and 4EBP1, as well as elevated phosphorylation of eIF2α, an inhibitor of mRNA translation. Remarkably, systemic treatment with ISRIB, a small molecule inhibitor that suppresses the effects of phosphorylated eIF2α on mRNA translation, was sufficient to reverse the social deficit and elevated anxiety-like behavior in adult cacna1c fbKO mice. ISRIB additionally normalized the lower protein synthesis and higher E/I ratio in the PFC. Thus this study identifies a novel Cav1.2 mechanism in neuropsychiatric-related endophenotypes and a potential future therapeutic target to explore.
This is a preview of subscription content, access via your institution
Access options
Similar content being viewed by others
References
Bhat S, Dao DT, Terrillion CE, Arad M, Smith RJ, Soldatov NM et al. CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease. Prog Neurobiol 2012; 99: 1–14.
Consortium C-DGotPG. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013; 381: 1371–1379.
Heyes S, Pratt WS, Rees E, Dahimene S, Ferron L, Owen MJ et al. Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders. Prog Neurobiol 2015; 134: 36–54.
Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008; 40: 1056–1058.
Green EK, Grozeva D, Jones I, Jones L, Kirov G, Caesar S et al. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry 2010; 15: 1016–1022.
Li J, Zhao L, You Y, Lu T, Jia M, Yu H et al. Schizophrenia Related Variants in CACNA1C also Confer Risk of Autism. PLoS ONE 2015; 10: e0133247.
Network, Pathway Analysis Subgroup of Psychiatric Genomics C. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat Neurosci 2015; 18: 199–209.
Simms BA, Zamponi GW . Neuronal voltage-gated calcium channels: structure, function, and dysfunction. Neuron 2014; 82: 24–45.
Pasca SP, Portmann T, Voineagu I, Yazawa M, Shcheglovitov A, Pasca AM et al. Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat Med 2011; 17: 1657–1662.
Zamponi GW, Striessnig J, Koschak A, Dolphin AC . The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential. Pharmacol Rev 2015; 67: 821–870.
Kabir ZD, Lee AS, Rajadhyaksha AM . L-type Ca channels in mood, cognition and addiction: Integrating human and rodent studies with a focus on behavioural endophenotypes. J Physiol 2016; 594: 5823–5837.
Miyoshi M, Morimura Y . Clinical manifestations of neuropsychiatric disorders. Neuropsychiatr Disord 2010; Part I: 1–14.
Millan MJ, Agid Y, Brune M, Bullmore ET, Carter CS, Clayton NS et al. Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov 2012; 11: 141–168.
Miller EK . The prefrontal cortex and cognitive control. Nat Rev Neurosci 2000; 1: 59–65.
Riga D, Matos MR, Glas A, Smit AB, Spijker S, Van den Oever MC . Optogenetic dissection of medial prefrontal cortex circuitry. Front Syst Neurosci 2014; 8: 230.
Wang F, McIntosh AM, He Y, Gelernter J, Blumberg HP . The association of genetic variation in CACNA1C with structure and function of a frontotemporal system. Bipolar Disord 2011; 13: 696–700.
Bicks LK, Koike H, Akbarian S, Morishita H . Prefrontal cortex and social cognition in mouse and man. Front Psychol 2015; 6: 1805.
Gao R, Penzes P . Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders. Curr Mol Med 2015; 15: 146–167.
Mullins C, Fishell G, Tsien RW . Unifying views of autism spectrum disorders: a consideration of autoregulatory feedback loops. Neuron 2016; 89: 1131–1156.
Nelson SB, Valakh V . Excitatory/inhibitory balance and circuit homeostasis in autism spectrum disorders. Neuron 2015; 87: 684–698.
Yizhar O, Fenno LE, Prigge M, Schneider F, Davidson TJ, O'Shea DJ et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 2011; 477: 171–178.
Santini E, Huynh TN, MacAskill AF, Carter AG, Pierre P, Ruggero D et al. Exaggerated translation causes synaptic and behavioural aberrations associated with autism. Nature 2013; 493: 411–415.
Gkogkas CG, Khoutorsky A, Ran I, Rampakakis E, Nevarko T, Weatherill DB et al. Autism-related deficits via dysregulated eIF4E-dependent translational control. Nature 2013; 493: 371–377.
Huynh TN, Shah M, Koo SY, Faraud KS, Santini E, Klann E . eIF4E/Fmr1 double mutant mice display cognitive impairment in addition to ASD-like behaviors. Neurobiol Dis 2015; 83: 67–74.
Buffington SA, Huang W, Costa-Mattioli M . Translational control in synaptic plasticity and cognitive dysfunction. Annu Rev Neurosci 2014; 37: 17–38.
Roussos P, Mitchell AC, Voloudakis G, Fullard JF, Pothula VM, Tsang J et al. A role for noncoding variation in schizophrenia. Cell Rep 2014; 9: 1417–1429.
Gershon ES, Grennan K, Busnello J, Badner JA, Ovsiew F, Memon S et al. A rare mutation of CACNA1C in a patient with bipolar disorder, and decreased gene expression associated with a bipolar-associated common SNP of CACNA1C in brain. Mol Psychiatry 2014; 19: 890–894.
Lee AS, Ra S, Rajadhyaksha AM, Britt JK, De Jesus-Cortes H, Gonzales KL et al. Forebrain elimination of cacna1c mediates anxiety-like behavior in mice. Mol Psychiatry 2012; 17: 1054–1055.
Inan M, Zhao M, Manuszak M, Karakaya C, Rajadhyaksha AM, Pickel VM et al. Energy deficit in parvalbumin neurons leads to circuit dysfunction, impaired sensory gating and social disability. Neurobiol Dis 2016; 93: 35–46.
Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 2006; 314: 140–143.
Detrait E, brohez C, Hanon E, De Ryck M . Automation of continuous spontaneous alternation to increase the thoughput for in vivo screening of cognitive enhancers. Optimization of the ethovision system for the Y-maze test in mice. Proceedings of Measuring Behavior, 7th International Conference on Methods and Techniques in Behavioral Research, Eindhoven, The Netherlands, 2010, pp 141–144.
Vorhees CV, Williams MT . Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 2006; 1: 848–858.
Che A, Girgenti MJ, LoTurco J . The dyslexia-associated gene DCDC2 is required for spike-timing precision in mouse neocortex. Biol Psychiatry 2014; 76: 387–396.
Schmidt EK, Clavarino G, Ceppi M, Pierre P . SUnSET, a nonradioactive method to monitor protein synthesis. Nat Methods 2009; 6: 275–277.
Tropea TF, Kabir ZD, Kaur G, Rajadhyaksha AM, Kosofsky BE . Enhanced dopamine D1 and BDNF signaling in the adult dorsal striatum but not nucleus accumbens of prenatal cocaine treated mice. Front Psychiatry 2011; 2: 67.
Kabir ZD, Katzman AC, Kosofsky BE . Molecular mechanisms mediating a deficit in recall of fear extinction in adult mice exposed to cocaine in utero. PLoS ONE 2013; 8: e84165.
Sidrauski C, Acosta-Alvear D, Khoutorsky A, Vedantham P, Hearn BR, Li H et al. Pharmacological brake-release of mRNA translation enhances cognitive memory. eLife 2013; 2: e00498.
Di Biase V, Obermair GJ, Szabo Z, Altier C, Sanguesa J, Bourinet E et al. Stable membrane expression of postsynaptic CaV1.2 calcium channel clusters is independent of interactions with AKAP79/150 and PDZ proteins. J Neurosci 2008; 28: 13845–13855.
Lee AS, De Jesus-Cortes H, Kabir ZD, Knobbe W, Orr M, Burgdorf C et al. The neuropsychiatric disease-associated gene cacna1c mediates survival of young hippocampal neurons. eNeuro 2016; 3: ENEURO.0006-16.2016.
Kempermann G, Krebs J, Fabel K . The contribution of failing adult hippocampal neurogenesis to psychiatric disorders. Curr Opin Psychiatry 2008; 21: 290–295.
Allsop SA, Vander Weele CM, Wichmann R, Tye KM . Optogenetic insights on the relationship between anxiety-related behaviors and social deficits. Front Behav Neurosci 2014; 8: 241.
Silverman JL, Yang M, Lord C, Crawley JN . Behavioural phenotyping assays for mouse models of autism. Nat Rev Neurosci 2010; 11: 490–502.
Stemmelin J, Cohen C, Terranova JP, Lopez-Grancha M, Pichat P, Bergis O et al. Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders. Neuropsychopharmacology 2008; 33: 574–587.
Hoffman KL . Modeling neuropsychiatric disorders in laboratory animals, 2016, ISBN: 978-0-08-100099-1.
Indovina I, Robbins TW, Nunez-Elizalde AO, Dunn BD, Bishop SJ . Fear-conditioning mechanisms associated with trait vulnerability to anxiety in humans. Neuron 2011; 69: 563–571.
Sartori SB, Hauschild M, Bunck M, Gaburro S, Landgraf R, Singewald N . Enhanced fear expression in a psychopathological mouse model of trait anxiety: pharmacological interventions. PLoS ONE 2011; 6: e16849.
Robinson OJ, Vytal K, Cornwell BR, Grillon C . The impact of anxiety upon cognition: perspectives from human threat of shock studies. Front Hum Neurosci 2013; 7: 203.
Lara AH, Wallis JD . The Role of Prefrontal Cortex in Working Memory: A Mini Review. Front Syst Neurosci 2015; 9: 173.
Darnell JC, Klann E . The translation of translational control by FMRP: therapeutic targets for FXS. Nat Neurosci 2013; 16: 1530–1536.
Costa-Mattioli M, Monteggia LM . mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nat Neurosci 2013; 16: 1537–1543.
Autry AE, Monteggia LM . Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 2012; 64: 238–258.
Duffney LJ, Zhong P, Wei J, Matas E, Cheng J, Qin L et al. Autism-like deficits in shank3-deficient mice are rescued by targeting actin regulators. Cell Rep 2015; 11: 1400–1413.
Tang G, Gudsnuk K, Kuo SH, Cotrina ML, Rosoklija G, Sosunov A et al. Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. Neuron 2014; 83: 1131–1143.
Samaco RC, McGraw CM, Ward CS, Sun Y, Neul JL, Zoghbi HY . Female Mecp2(+/-) mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies. Hum Mol Genet 2013; 22: 96–109.
Zhang W, Peterson M, Beyer B, Frankel WN, Zhang ZW . Loss of MeCP2 from forebrain excitatory neurons leads to cortical hyperexcitation and seizures. J Neurosci 2014; 34: 2754–2763.
Sceniak MP, Lang M, Enomoto AC, Howell CJ, Hermes DJ, Katz DM . Mechanisms of functional hypoconnectivity in the medial prefrontal cortex of Mecp2 null mice. Cereb Cortex 2016; 26: 1938–1956.
Bigos KL, Mattay VS, Callicott JH, Straub RE, Vakkalanka R, Kolachana B et al. Genetic variation in CACNA1C affects brain circuitries related to mental illness. Arch Gen Psychiatry 2010; 67: 939–945.
Yoshimizu T, Pan JQ, Mungenast AE, Madison JM, Su S, Ketterman J et al. Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons. Mol Psychiatry 2015; 20: 162–169.
Eckart N, Song Q, Yang R, Wang R, Zhu H, McCallion AS et al. Functional Characterization of Schizophrenia-Associated Variation in CACNA1C. PLoS ONE 2016; 11: e0157086.
Bader PL, Faizi M, Kim LH, Owen SF, Tadross MR, Alfa RW et al. Mouse model of Timothy syndrome recapitulates triad of autistic traits. Proc Natl Acad Sci USA 2011; 108: 15432–15437.
Roussos P, Giakoumaki SG, Georgakopoulos A, Robakis NK, Bitsios P . The CACNA1C and ANK3 risk alleles impact on affective personality traits and startle reactivity but not on cognition or gating in healthy males. Bipolar Disord 2011; 13: 250–259.
Dietsche B, Backes H, Laneri D, Weikert T, Witt SH, Rietschel M et al. The impact of a CACNA1C gene polymorphism on learning and hippocampal formation in healthy individuals: a diffusion tensor imaging study. Neuroimage 2014; 89: 256–261.
Erk S, Meyer-Lindenberg A, Linden DE, Lancaster T, Mohnke S, Grimm O et al. Replication of brain function effects of a genome-wide supported psychiatric risk variant in the CACNA1C gene and new multi-locus effects. Neuroimage 2014; 94: 147–154.
Erk S, Meyer-Lindenberg A, Schnell K, Opitz von Boberfeld C, Esslinger C, Kirsch P et al. Brain function in carriers of a genome-wide supported bipolar disorder variant. Arch Gen Psychiatry 2010; 67: 803–811.
Hori H, Yamamoto N, Fujii T, Teraishi T, Sasayama D, Matsuo J et al. Effects of the CACNA1C risk allele on neurocognition in patients with schizophrenia and healthy individuals. Sci Rep 2012; 2: 634.
Murray AJ, Woloszynowska-Fraser MU, Ansel-Bollepalli L, Cole KL, Foggetti A, Crouch B et al. Parvalbumin-positive interneurons of the prefrontal cortex support working memory and cognitive flexibility. Sci Rep 2015; 5: 16778.
Koester SE, Insel TR . Understanding how non-coding genomic polymorphisms affect gene expression. Mol Psychiatry 2016; 21: 448–449.
Calhoon GG, Tye KM . Resolving the neural circuits of anxiety. Nat Neurosci 2015; 18: 1394–1404.
Liang J, Xu W, Hsu YT, Yee AX, Chen L, Sudhof TC . Conditional neuroligin-2 knockout in adult medial prefrontal cortex links chronic changes in synaptic inhibition to cognitive impairments. Mol Psychiatry 2015; 20: 850–859.
Han S, Tai C, Westenbroek RE, Yu FH, Cheah CS, Potter GB et al. Autistic-like behaviour in Scn1a+/- mice and rescue by enhanced GABA-mediated neurotransmission. Nature 2012; 489: 385–390.
Zimmerman HR, Beckelman B, Yang W, Ma T . Interactions between the eIF2a and mTORC1 signaling pathways. Program No 12602 2016 Neuroscience Meeting Planner. Society for Neuroscience, Online: San Diego, CA, USA, 2016.
Ricciardi S, Boggio EM, Grosso S, Lonetti G, Forlani G, Stefanelli G et al. Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. Hum Mol Genet 2011; 20: 1182–1196.
Tao J, Hu K, Chang Q, Wu H, Sherman NE, Martinowich K et al. Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function. Proc Natl Acad Sci USA 2009; 106: 4882–4887.
Gemelli T, Berton O, Nelson ED, Perrotti LI, Jaenisch R, Monteggia LM . Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice. Biol Psychiatry 2006; 59: 468–476.
Nicolini C, Ahn Y, Michalski B, Rho JM, Fahnestock M . Decreased mTOR signaling pathway in human idiopathic autism and in rats exposed to valproic acid. Acta Neuropathol Commun 2015; 3: 3.
Costa-Mattioli M, Gobert D, Stern E, Gamache K, Colina R, Cuello C et al. eIF2alpha phosphorylation bidirectionally regulates the switch from short- to long-term synaptic plasticity and memory. Cell 2007; 129: 195–206.
Costa-Mattioli M, Gobert D, Harding H, Herdy B, Azzi M, Bruno M et al. Translational control of hippocampal synaptic plasticity and memory by the eIF2alpha kinase GCN2. Nature 2005; 436: 1166–1173.
Trinh MA, Ma T, Kaphzan H, Bhattacharya A, Antion MD, Cavener DR et al. The eIF2alpha kinase PERK limits the expression of hippocampal metabotropic glutamate receptor-dependent long-term depression. Learn Mem 2014; 21: 298–304.
Trinh MA, Kaphzan H, Wek RC, Pierre P, Cavener DR, Klann E . Brain-specific disruption of the eIF2alpha kinase PERK decreases ATF4 expression and impairs behavioral flexibility. Cell Rep 2012; 1: 676–688.
Sidrauski C, McGeachy AM, Ingolia NT, Walter P . The small molecule ISRIB reverses the effects of eIF2alpha phosphorylation on translation and stress granule assembly. eLife 2015; 4; doi: 10.7554/eLife.05033.
Dolmetsch RE, Pajvani U, Fife K, Spotts JM, Greenberg ME . Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway. Science 2001; 294: 333–339.
Klann E, Dever TE . Biochemical mechanisms for translational regulation in synaptic plasticity. Nat Rev Neurosci 2004; 5: 931–942.
Sutton MA, Schuman EM . Dendritic protein synthesis, synaptic plasticity, and memory. Cell 2006; 127: 49–58.
Pasini S, Corona C, Liu J, Greene LA, Shelanski ML . Specific downregulation of hippocampal ATF4 reveals a necessary role in synaptic plasticity and memory. Cell Rep 2015; 11: 183–191.
Nadif Kasri N, Nakano-Kobayashi A, Van Aelst L . Rapid synthesis of the X-linked mental retardation protein OPHN1 mediates mGluR-dependent LTD through interaction with the endocytic machinery. Neuron 2011; 72: 300–315.
Di Prisco GV, Huang W, Buffington SA, Hsu CC, Bonnen PE, Placzek AN et al. Translational control of mGluR-dependent long-term depression and object-place learning by eIF2alpha. Nat Neurosci 2014; 17: 1073–1082.
Rudell JB, Rechs AJ, Kelman TJ, Ross-Inta CM, Hao S, Gietzen DW . The anterior piriform cortex is sufficient for detecting depletion of an indispensable amino acid, showing independent cortical sensory function. J Neurosci 2011; 31: 1583–1590.
Zheng F, Zhou X, Luo Y, Xiao H, Wayman G, Wang H . Regulation of brain-derived neurotrophic factor exon IV transcription through calcium responsive elements in cortical neurons. PLoS ONE 2011; 6: e28441.
Mounir Z, Krishnamoorthy JL, Wang S, Papadopoulou B, Campbell S, Muller WJ et al. Akt determines cell fate through inhibition of the PERK-eIF2alpha phosphorylation pathway. Sci Signal 2011; 4: ra62.
Acknowledgements
This work was supported by The Hartwell Foundation (AMR), the Weill Cornell Autism Research Program (AMR), the Weill Cornell Medicine Postdoctoral Fellowship (ZDK), the National Institutes of Health (5R01DA029122 to AMR; 5 R00 MH095825 05 and 1 R01 MH110553 01 to NVDMG), Leon Levy Foundation (NVDMG), and Citizens United for Research in Epilepsy (CURE; NVDMG). We thank Dr Jacqueline Crawley for technical assistance with establishing the social interaction behavioral apparatus and procedure in our laboratory. We thank Drs Eric Klann, Aditi Bhattacharya, Alexandra Cohen and Anni Lee for technical assistance with establishing the water-based Y-maze behavioral paradigm in our laboratory. We thank Dr Andrew Pieper for critical reading of the manuscript and Dr Héctor De Jesús-Cortés for his comments on the figures.
Author contributions
ZDK and AMR contributed to the experimental design, data interpretation and wrote the paper. AC and NVDMG performed electrophysiological experiments and analyzed data. ZDK performed stereotaxic surgeries and analyzed data. ZDK and DKF conducted molecular and behavioral experiments. BR conducted molecular experiments. RCR and MB conducted behavioral experiments. MJG conducted electron microscopy experiments. All authors discussed and commented on the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Molecular Psychiatry website
Supplementary information
Rights and permissions
About this article
Cite this article
Kabir, Z., Che, A., Fischer, D. et al. Rescue of impaired sociability and anxiety-like behavior in adult cacna1c-deficient mice by pharmacologically targeting eIF2α. Mol Psychiatry 22, 1096–1109 (2017). https://doi.org/10.1038/mp.2017.124
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2017.124
This article is cited by
-
Mammalian integrated stress responses in stressed organelles and their functions
Acta Pharmacologica Sinica (2024)
-
Phenotypes, mechanisms and therapeutics: insights from bipolar disorder GWAS findings
Molecular Psychiatry (2022)
-
Neuronal deletion of CaV1.2 is associated with sex-specific behavioral phenotypes in mice
Scientific Reports (2022)
-
Inhibition of the ISR abrogates mGluR5-dependent long-term depression and spatial memory deficits in a rat model of Alzheimer’s disease
Translational Psychiatry (2022)
-
Enhanced long-term potentiation and impaired learning in mice lacking alternative exon 33 of CaV1.2 calcium channel
Translational Psychiatry (2022)